Paul Mintz Nuo Therapeutics, Inc. (AURX) insider trading activity

AURX Quotes by TradingView

Paul Mintz is Director of Nuo Therapeutics, Inc.. Currently has a direct ownership of 108,294 shares of AURX, which is worth approximately $228,500. The most recent transaction as insider was on Dec 09, 2025, when has been sold 9,091 shares (Common Stock) at a price of $2.2 per share, resulting in proceeds of $20,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 108K
60.71% 3M change
n/a 12M change
Total Value Held $228,500

Paul Mintz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2025
SELL
Payment of exercise price or tax liability
$20,000 $2.2 p/Share
9,091 Reduced 7.74%
108,294 Common Stock
Dec 09 2025
BUY
Exercise of conversion of derivative security
$20,000 $0.4 p/Share
50,000 Added 29.87%
117,385 Common Stock
Aug 01 2025
SELL
Payment of exercise price or tax liability
$35,000 $1.74 p/Share
20,115 Reduced 22.99%
67,385 Common Stock
Aug 01 2025
BUY
Exercise of conversion of derivative security
$35,000 $0.4 p/Share
87,500 Added 50.0%
87,500 Common Stock
PM

Paul Mintz

Director
Houston, TX

Track Institutional and Insider Activities on AURX

Follow Nuo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AURX shares.

Notify only if

Insider Trading

Get notified when an Nuo Therapeutics, Inc. insider buys or sells AURX shares.

Notify only if

News

Receive news related to Nuo Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AURX